DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAFoundationMRCS

Haemoglobin electrophoresis and carrier counselling

Essential points for quick revision.

!
Escalate

Haemoglobin analysis is rarely an emergency test. Do not delay treatment of suspected sickle crisis, acute chest syndrome, severe anaemia or newborn illness while awaiting fractionation. In pregnancy, however, a result suggesting a clinically important carrier state needs prompt partner testing and screening-team referral because the window for diagnostic options is time limited.

Synopsis

Select and interpret haemoglobin analysis in context, recognise assay and transfusion limitations, confirm consequential variants molecularly, and translate paired results into non-directive reproductive counselling.

  • Modern laboratories use high-performance liquid chromatography, capillary electrophoresis, isoelectric focusing or complementary methods; the report must be interpreted with method, age and clinical question.
  • Adult haemoglobin A predominates normally, with small HbA2 and HbF fractions; newborns predominantly express HbF, so infant patterns use different algorithms.
  • Raised HbA2 supports beta-thalassaemia trait, but iron deficiency, transfusion, delta-chain variants and coexisting haemoglobin variants can alter the result.

Key red flags

Time-critical pregnancy result

A pregnant carrier whose partner is untested needs prompt screening coordination so fetal-risk assessment and options are not delayed.

Investigation priorities

01
Full blood count and red-cell indicesFirst step

Provide globin-production context for the fraction pattern.

Management branches

Test selectionStart with the clinical question

Microcytosis, haemolysis, family history, pregnancy or newborn screening raises haemoglobinopathy.

  1. Provide age, pregnancy, transfusion date, hydroxycarbamide exposure, full count and iron status to the accredited laboratory.
  2. Use quantitative haemoglobin separation rather than a solubility screen for carrier or disease classification and retain any pre-transfusion sample.
Open full textbook Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom